Ultralife Co. (NASDAQ:ULBI – Get Free Report) Director W. Shaw Robert purchased 2,500 shares of the stock in a transaction dated Tuesday, November 12th. The shares were acquired at an average price of $7.91 per share, with a total value of $19,775.00. Following the completion of the acquisition, the director now owns 65,250 shares in the company, valued at approximately $516,127.50. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Ultralife Price Performance
ULBI stock opened at $8.00 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.07 and a quick ratio of 2.06. The firm has a market capitalization of $132.96 million, a P/E ratio of 14.55 and a beta of 0.98. The business’s 50-day moving average is $9.09 and its two-hundred day moving average is $10.32. Ultralife Co. has a 1 year low of $6.36 and a 1 year high of $13.39.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Ultralife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, October 3rd.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Quadrature Capital Ltd purchased a new position in shares of Ultralife in the 1st quarter valued at about $200,000. Empowered Funds LLC lifted its holdings in shares of Ultralife by 7.8% in the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after buying an additional 2,275 shares during the period. O Shaughnessy Asset Management LLC acquired a new stake in shares of Ultralife in the 1st quarter valued at approximately $100,000. Hillsdale Investment Management Inc. acquired a new position in Ultralife during the first quarter worth $166,000. Finally, Vanguard Group Inc. raised its holdings in Ultralife by 1.3% during the first quarter. Vanguard Group Inc. now owns 515,840 shares of the technology company’s stock worth $4,545,000 after purchasing an additional 6,640 shares during the last quarter. Hedge funds and other institutional investors own 30.68% of the company’s stock.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More
- Five stocks we like better than Ultralife
- Dividend Payout Ratio Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Breakout Stocks: What They Are and How to Identify Them
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- With Risk Tolerance, One Size Does Not Fit All
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.